Manuel Opitz active positions
| Companies | Position | Start | End |
|---|---|---|---|
Mecuris GmbH
 Mecuris GmbH Commercial Printing/FormsCommercial Services Mecuris GmbH operates a software platform for automatic generation of patient-customized orthoses and prosthetic designs. The company was founded by Manuel Opitz, Wolf-Peter Werner, Felix Gundlack, Jannis Breuninger and Simon Weidert and is headquartered in Munich, Germany. | Founder | 2016-06-21 | - |
| Corporate Officer/Principal | 2016-06-21 | - | |
Deepeye Medical GmbH
 Deepeye Medical GmbH Information Technology ServicesTechnology Services Deepeye Medical GmbH is a German medical company that aims to address the issue of millions going blind every year despite effective retinal therapy. The private company is located in Germany. The company's co-founders have developed a 2nd-opinion-approach using AI to scale their solution. The company also offers Deepeye® research, which unlocks the future of clinical studies. | Chief Executive Officer | 2020-12-31 | - |
| Founder | 2020-12-31 | - |
Career history of Manuel Opitz
Statistics
International
| Germany | 3 |
Operational
| Founder | 2 |
| Corporate Officer/Principal | 1 |
| Chief Executive Officer | 1 |
Sectoral
| Commercial Services | 2 |
| Technology Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Mecuris GmbH
Mecuris GmbH Commercial Printing/FormsCommercial Services Mecuris GmbH operates a software platform for automatic generation of patient-customized orthoses and prosthetic designs. The company was founded by Manuel Opitz, Wolf-Peter Werner, Felix Gundlack, Jannis Breuninger and Simon Weidert and is headquartered in Munich, Germany. | Commercial Services |
Deepeye Medical GmbH
Deepeye Medical GmbH Information Technology ServicesTechnology Services Deepeye Medical GmbH is a German medical company that aims to address the issue of millions going blind every year despite effective retinal therapy. The private company is located in Germany. The company's co-founders have developed a 2nd-opinion-approach using AI to scale their solution. The company also offers Deepeye® research, which unlocks the future of clinical studies. | Technology Services |
- Stock Market
- Insiders
- Manuel Opitz
- Experience
